Skip to main content
Michael Davidson, MD, Cardiology, Chicago, IL

MichaelDavidsonMD

Cardiology Chicago, IL

Preventive Cardiology

Clinical Professor of Medicine, University of Chicago Medicine

Dr. Davidson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Davidson's full profile

Already have an account?

  • Office

    5841 S Maryland Ave
    Chicago, IL 60637
    Phone+1 888-824-0200
    Fax+1 773-834-7300

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterFellowship, Cardiovascular Disease, 1984 - 1986
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1981 - 1984
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1981

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1982 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Lectures

  • The Power of Prevention: Lipid-Lowering Strategies for Cardiovascular Risk Reduction 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Lower TogetherLDL-C, Risk, Hassle, Cost 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
  • How to Build a Successful Lipid Clinic 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Press Mentions

  • As Assaults by Patients Become Increasingly ‘Part of the Job,’ Nurses and Hospitals Lobby for New Law
    As Assaults by Patients Become Increasingly ‘Part of the Job,’ Nurses and Hospitals Lobby for New LawMarch 29th, 2025
  • NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia
    NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial HypercholesterolemiaDecember 10th, 2024
  • Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?
    Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?August 15th, 2022
  • Join now to see all

Committees

  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015

Professional Memberships